NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
| Drug Number: | 531/09 |
| Drug Name: | pemetrexed (Alimta) |
| Drug Manufacturer: | Eli Lilly & Company Ltd |
| BNF Category: | Malignant disease and immunosuppression |
| Submission type : | Resubmission |
| Date Advice Issued: | 08.06.09 |
| Indication: | First line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) |